identified a cluster of adi‐CAFs derived from adipocyte precursor cells, which secrete neuregulin 1 and contribute to drug resistance in urothelial carcinoma.[34] In the present study, adi‐CAFs were found to upregulate pathways associated with cancer progression, such as angiogenesis. Here, NRG1 is linked to urothelial carcinoma.